BRIEF

on IMPLANET (EPA:ALIMP)

IMPLANET publishes its 2024 half-yearly financial report

Stock price chart of IMPLANET (EPA:ALIMP) showing fluctuations.

IMPLANET, a medical technology company specializing in orthopedic surgery, has published its half-yearly financial report for the first half of 2024. The report is available on the IMPLANET website and on that of the Autorité des Marchés Financiers (AMF).

The company, listed on Euronext Growth, has posted the documents required for its shareholders and investors to comply with its financial transparency obligations. The next financial press release concerning the third quarter 2024 revenue will be published after the close of trading on October 8, 2024.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all IMPLANET news